150
Participants
Start Date
July 18, 2019
Primary Completion Date
November 15, 2026
Study Completion Date
November 15, 2026
Citadel Embolization Device
The Citadel Embolization Device is intended to endovascularly obstruct or occlude blood flow in intracranial aneurysms.
Weill Cornell, New York
Montefiore Medical Center, New York
University of Pennsylvania Hospital, Philadelphia
Thomas Jefferson University, Philadelphia
West Virginia University Hospital, Morgantown
Baptist Health, Jacksonville
University of Florida, Gainesville
University of Miami/Jackson Memorial, Miami
Tampa General Hospital, Tampa
Baptist Health, Lexington
University of Kentucky, Lexington
Cleveland Clinic, Cleveland
Indiana Methodist, Indianapolis
McLaren Health Center, Flint
Spectrum Health, Grand Rapids
Northwestern University, Chicago
Washington University, St Louis
Kansas University Medical Center, Kansas City
RIA Neurovascular, Englewood
Carondelet St. Joseph Hospital, Tucson
Cedars-Sinai Medical Center, Los Angeles
California Pacific Medical Center, San Francisco
UCSF Medical Center, San Francisco
John Muir Health, Walnut Creek
University of Washington, Seattle
UMass Memorial Health, Worcester
Stryker Neurovascular
INDUSTRY